ALLERGAN AUSTRALIA PTY LIMITED

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada

Withdrawn

Conditions: Uterine Fibroids

First Posted Date: 2020-09-28

Last Posted Date: 2020-10-22

Lead Sponsor: Allergan

Registration Number: NCT04567589

Locations: 🇺🇸
Clinical Trials Registry Team, Irvine, California, United States

JUVÉDERM VOLUX® for Chin Retrusion in China

Phase 3

Completed

Conditions: Chin Retrusion

Interventions: Device: JUVÉDERM VOLUX®

First Posted Date: 2020-09-23

Last Posted Date: 2023-08-21

Lead Sponsor: Allergan

Target Recruit Count: 150

Registration Number: NCT04559984

Locations: 🇨🇳
Nanfang Hospital of Southern Medical University /ID# 224442, Guangzhou, Guangdong, China
🇨🇳
Plastic Surgery Hospital(Institute), Cams, Pumc /ID# 224441, Beijing, Beijing, China
🇨🇳
Peking University International Hospital /ID# 224438, Beijing, China

and more 4 locations

Evaluation of Age-related Skin Changes and Instrument Reliability Using Clinical Probe Measurements and Imaging Modalities

Completed

Conditions: Age-related Skin Changes

First Posted Date: 2020-09-17

Last Posted Date: 2021-03-09

Lead Sponsor: Allergan

Target Recruit Count: 200

Registration Number: NCT04552249

Locations: 🇫🇷
Dermscan-Pharmascan, Villeurbanne, France

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

Phase 3

Completed

Conditions: Temple Hollowing

Interventions: Device: JUVÉDERM® VOLUMA® XC
Other: No-treatment control

First Posted Date: 2020-06-04

Last Posted Date: 2024-04-25

Lead Sponsor: Allergan

Target Recruit Count: 205

Registration Number: NCT04414397

Locations: 🇺🇸
Skin Care and Laser Physicians of Beverly Hills /ID# 232967, Los Angeles, California, United States
🇺🇸
Steve Yoelin MD Medical Associate Inc /ID# 232956, Newport Beach, California, United States
🇺🇸
Steven Fagien MD PA /ID# 232807, Boca Raton, Florida, United States

and more 12 locations

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

Phase 3

Completed

Conditions: Dry Eye Disease (DED)

Interventions: Drug: Systane Ultra Multidose
Drug: 011516X (New Artificial Tear Formulation)
Drug: REFRESH PLUS®

First Posted Date: 2020-05-19

Last Posted Date: 2024-06-26

Lead Sponsor: Allergan

Target Recruit Count: 400

Registration Number: NCT04393441

Locations: 🇺🇸
Milton M. Hom, OD, FAAO, Azusa, California, United States
🇺🇸
Nature Coast Clinical Research, Crystal River, Florida, United States
🇺🇸
Vista Health Research, LLC, Miami, Florida, United States

and more 23 locations

A Study to Evaluate the Effect of Juvederm Volift With Lidocaine on Aging Hands in Participants Age 35 and Older

Phase 4

Completed

Conditions: Skin Depressions
Skin Laxity
Skin Elasticity

Interventions: Device: Juvéderm® VOLIFT with Lidocaine

First Posted Date: 2020-05-15

Last Posted Date: 2022-12-12

Lead Sponsor: Allergan

Target Recruit Count: 75

Registration Number: NCT04390581

Locations: 🇫🇷
Eurofins Pharmascan /ID# 233683, Lyon, France

A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

Phase 4

Completed

Conditions: Hypogonadism

Interventions: Drug: Androderm®

First Posted Date: 2020-03-25

Last Posted Date: 2022-07-12

Lead Sponsor: Allergan

Target Recruit Count: 168

Registration Number: NCT04320745

Locations: 🇺🇸
Coastal Clinical Research, LLC, An AMR Co., Mobile, Alabama, United States
🇺🇸
Regional Urology, LLC, Shreveport, Louisiana, United States
🇺🇸
Associated Urologist of North Carolina, Raleigh, North Carolina, United States

and more 37 locations

Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma

Completed

Conditions: Refractory Glaucoma

Interventions: Device: XEN Glaucoma Stent

First Posted Date: 2020-03-11

Last Posted Date: 2024-04-12

Lead Sponsor: Allergan

Target Recruit Count: 59

Registration Number: NCT04303897

Locations: 🇨🇳
Boao Super Hospital /ID# 233669, Qionghai, Hainan, China

A Retrospective Chart Review Study to Evaluate Safety of McGhan Single Lumen Gel-Filled Breast Implants in Patients in China

Completed

Conditions: Breast Augmentation
Breast Reconstruction

First Posted Date: 2020-02-10

Last Posted Date: 2020-09-21

Lead Sponsor: Allergan

Target Recruit Count: 225

Registration Number: NCT04261608

Locations: 🇨🇳
Beijing Lidu Plastic Surgery Hospital, Beijing, Beijing, China
🇨🇳
Guangzhou Sogood Medical Cosmetology Hospital, Guangzhou, Guangdong, China
🇨🇳
The Second People's Hospital of Guangdong Province, Guangzhou, Guangdong, China

and more 3 locations

A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers

Not Applicable

Completed

Conditions: Skin Enhancement
Healthy Adults

Interventions: Device: Juvederm® VOLITE

First Posted Date: 2019-12-20

Last Posted Date: 2021-08-26

Lead Sponsor: Allergan

Target Recruit Count: 11

Registration Number: NCT04206293

Locations: 🇵🇱
EuroFins Dermscan Poland, Gdansk, Poland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy